Overview Financials News + Filings Key Docs Ownership
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
NuCana plc (NCNA)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/13/2023 |
6-K
| Quarterly results |
08/16/2023 |
6-K
| Quarterly results |
06/16/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
05/17/2023 |
6-K
| Quarterly results |
05/12/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
|
"6-K",
"NuCana Announces Receipt of Nasdaq Notice Edinburgh, United Kingdom, May 12, 2023 - NuCana plc announced that it received written notification from The Nasdaq Stock Market LLC dated May 9, 2023, indicating that, based upon a closing bid price of less than $1.00 per share for the Company's American Depositary Shares for the prior 30 consecutive business day period, the Company no longer satisfies Nasdaq Listing Rule 5450. The Notification Letter has no immediate effect on the listing of the ADSs, and they will continue to trade on The Nasdaq Global Select Market under the symbol “NCNA”. Pursuant to Nasdaq Listing Rule 5810, the applicable grace period to regain compliance is 180 days, or until November 6, 2023. The Company intends to monitor the closing bid price of its ADSs during this gra..." |
|
04/14/2023 |
6-K
| Quarterly results |
04/04/2023 |
20-F
| Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: |
04/04/2023 |
6-K
| Quarterly results |
03/24/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/23/2023 |
SC 13G/A
| BAILLIE GIFFORD & CO reports a 7% stake in NUCANA PLC |
01/23/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
|
"6-K",
"NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement Edinburgh, United Kingdom, January 23, 2023 - NuCana plc , , announced that it has received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market, LLC informing the Company that it has regained compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5450 and the matter is closed. As announced on January 6, 2023, the Company was notified by Nasdaq that it was not in compliance with the Minimum Bid Price Requirement, as the closing bid price of the Company's American Depositary Shares had been below $1.00 for 30 consecutive business days. To regain compliance with the Minimum Bid Price Requirement, NuCana was required to maintain a minimu..." |
|
01/06/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
|
"6-K",
"NuCana Announces Receipt of NASDAQ Notice Edinburgh, United Kingdom, January 6, 2023 - NuCana plc announced that it received written notification from The Nasdaq Stock Market LLC dated January 3, 2023, indicating that, based upon a closing bid price of less than $1.00 per share for the Company's American Depositary Shares for the prior 30 consecutive business day period, the Company no longer satisfies Nasdaq Listing Rule 5450. The Notification Letter has no immediate effect on the listing of the ADSs, and they will continue to trade on The Nasdaq Global Select Market under the symbol “NCNA”. Pursuant to Nasdaq Listing Rule 5810, the applicable grace period to regain compliance is 180 days, or until July 3, 2023. The Company intends to monitor the closing bid price of its ADSs during this ..." |
|
11/16/2022 |
6-K
| Quarterly results |
10/26/2022 |
6-K
| Quarterly results |
09/12/2022 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
09/12/2022 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
09/06/2022 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
|
"6-K",
"NuCana Announces Presentations at the European Society for Medical Oncology Congress 2022 Edinburgh, United Kingdom, September 6, 2022 —NuCana plc announced two presentations at the European Society for Medical Oncology Congress 2022 being held September 9-13, 2022 at the Paris Expo Porte de Versailles in Paris, France. The details of NuCana's presentations at ESMO are as follows: Title: NUC-3373, a ProTide transformation of 5-FU, in combination with oxaliplatin or irinotecan in patients with advanced colorectal cancer Abstract Number: 1752 Presentation: 345P Presentation Date & Time: Sunday, September 11, 2022 at 9:00 a.m. CEST Location: Hall 4 and the virtual Congress platform Presenting Author: Andrew L. Coveler Title: NUC-7738 in patients with advanced solid tumours: Phase I results f..." |
|
08/17/2022 |
6-K
| Quarterly results |
08/11/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
07/27/2022 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
|
"6-K",
"NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement Edinburgh, United Kingdom, July 27, 2022 - NuCana plc , , announced that it has received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market, LLC informing the Company that it has regained compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5450 and the matter is closed. As announced on June 3, 2022, the Company was notified by Nasdaq that it was not in compliance with the Minimum Bid Price Requirement, as the closing bid price of the Company's American Depositary Shares had been below $1.00 for 30 consecutive business days. To regain compliance with the Minimum Bid Price Requirement, NuCana was required to maintain a minimum clos..." |
|
07/11/2022 |
6-K
| Quarterly results |
06/23/2022 |
6-K
| Quarterly results |
06/10/2022 |
6-K
| Quarterly results |
06/03/2022 |
6-K
| Quarterly results |
06/02/2022 |
6-K
| Quarterly results |
05/23/2022 |
6-K
| Quarterly results |
04/27/2022 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
03/08/2022 |
6-K
| Quarterly results |
03/02/2022 |
6-K
| Quarterly results |
02/25/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
02/22/2022 |
6-K
| Quarterly results |
02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|